Effectiveness, Efficacy, and Safety of XGEVA (denosumab) in Chinese Patients With Giant Cell Tumor of Bone (GCTB): A Systematic Literature Review (20220044)

ENCePP Code of conduct

No

Data sources

• Data source(s), other:
  PubMed (MEDLINE) United States, Embase United States, Google Scholar United States, Cochrane Library United States, Clarivate Analytics United States
• Data sources (types):
  Administrative healthcare records (e.g., claims)

  Other
• Data sources (types), other:
  Systematic review of all published studies of XGEVA among mainland Chinese and Chinese patients in Taiwan, Hong Kong, and Macau with GCTB.

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No